NovoCure (NVCR) Net Margin (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,682.00 |
| Dec 31, 2025 | 824.00 |
| Sep 30, 2025 | 299.00 |
| Jun 30, 2025 | -313.00 |
| Mar 31, 2025 | 1,874.00 |
| Dec 31, 2024 | -2,117.00 |
| Sep 30, 2024 | 249.00 |
| Jun 30, 2024 | 579.00 |
| Mar 31, 2024 | 721.00 |
| Dec 31, 2023 | 368.00 |
| Sep 30, 2023 | 669.00 |
| Jun 30, 2023 | -212.00 |
| Mar 31, 2023 | -1,438.00 |
| Dec 31, 2022 | -876.00 |
| Sep 30, 2022 | -324.00 |
| Jun 30, 2022 | -1,366.00 |
| Mar 31, 2022 | 1,648.00 |
| Dec 31, 2021 | -1,004.00 |
| Sep 30, 2021 | 114.00 |
| Jun 30, 2021 | -790.00 |
| Mar 31, 2021 | -648.00 |
| Dec 31, 2020 | -358.00 |
| Sep 30, 2020 | 557.00 |
| Jun 30, 2020 | -245.00 |
| Mar 31, 2020 | -41.00 |
| Dec 31, 2019 | 220.00 |
| Sep 30, 2019 | 356.00 |
| Jun 30, 2019 | 1,511.00 |
| Mar 31, 2019 | 586.00 |
| Dec 31, 2018 | -438.00 |
| Sep 30, 2018 | 716.00 |
| Jun 30, 2018 | 1,454.00 |
| Mar 31, 2018 | -1,936.00 |
| Dec 31, 2017 | 255.00 |
| Sep 30, 2017 | 3,223.00 |
| Jun 30, 2017 | -344.00 |
| Mar 31, 2017 | -24,624.00 |
| Dec 31, 2016 | 34,965.00 |
| Sep 30, 2016 | 7,149.00 |
| Jun 30, 2016 | 4,484.00 |
| Mar 31, 2016 | -557.00 |
| Dec 31, 2015 | 2,475.00 |
| Sep 30, 2015 | 15,802.00 |
| Jun 30, 2015 | -181.00 |
| Mar 31, 2015 | -137,739.00 |
| Dec 31, 2014 | 134,936.00 |